Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6888
pubmed:dateCreated
2002-5-30
pubmed:abstractText
Myelin-derived axon outgrowth inhibitors, such as Nogo, may account for the lack of axonal regeneration in the central nervous system (CNS) after trauma in adult mammals. A 66-residue domain of Nogo (Nogo-66) is expressed on the surface of oligodendrocytes and can inhibit axonal outgrowth through an axonal Nogo-66 receptor (NgR). The IN-1 monoclonal antibody recognizes Nogo-A and promotes corticospinal tract regeneration and locomotor recovery; however, the undefined nature of the IN-1 epitope in Nogo, the limited specificity of IN-1 for Nogo, and nonspecific anti-myelin effects have prevented a firm conclusion about the role of Nogo-66 or NgR. Here, we identify competitive antagonists of NgR derived from amino-terminal peptide fragments of Nogo-66. The Nogo-66(1 40) antagonist peptide (NEP1 40) blocks Nogo-66 or CNS myelin inhibition of axonal outgrowth in vitro, demonstrating that NgR mediates a significant portion of axonal outgrowth inhibition by myelin. Intrathecal administration of NEP1 40 to rats with mid-thoracic spinal cord hemisection results in significant axon growth of the corticospinal tract, and improves functional recovery. Thus, Nogo-66 and NgR have central roles in limiting axonal regeneration after CNS injury, and NEP1-40 provides a potential therapeutic agent.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0028-0836
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
417
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
547-51
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12037567-Amino Acid Sequence, pubmed-meshheading:12037567-Animals, pubmed-meshheading:12037567-Axons, pubmed-meshheading:12037567-Binding, Competitive, pubmed-meshheading:12037567-Central Nervous System, pubmed-meshheading:12037567-Culture Media, Conditioned, pubmed-meshheading:12037567-Female, pubmed-meshheading:12037567-GPI-Linked Proteins, pubmed-meshheading:12037567-Growth Cones, pubmed-meshheading:12037567-Molecular Sequence Data, pubmed-meshheading:12037567-Motor Activity, pubmed-meshheading:12037567-Myelin Proteins, pubmed-meshheading:12037567-Myelin Sheath, pubmed-meshheading:12037567-Nerve Regeneration, pubmed-meshheading:12037567-Neurites, pubmed-meshheading:12037567-Peptide Fragments, pubmed-meshheading:12037567-Protein Structure, Tertiary, pubmed-meshheading:12037567-Rats, pubmed-meshheading:12037567-Rats, Sprague-Dawley, pubmed-meshheading:12037567-Receptors, Cell Surface, pubmed-meshheading:12037567-Spinal Cord Injuries
pubmed:year
2002
pubmed:articleTitle
Nogo-66 receptor antagonist peptide promotes axonal regeneration.
pubmed:affiliation
Department of Neurology and Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't